Studies how glucose metabolism, diabetes, and hyperglycemia influence brain function and Alzheimer's disease risk. Combines glucose-clamp methods with in vivo microdialysis to measure real-time amyloid-beta, glucose, and lactate dynamics and to evaluate metabolic ion channels as therapeutic targets.